Skip to content
Screener

Absci Corporation ABSI Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$2.06M-22.1%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$418K+186%
Xencor logo
XencorXNCR
$7K
Sutro Biopharma logo
Sutro BiopharmaSTRO
$445K-60.1%

Other financials

Income statement

See full
Revenue$318.0K-46.4%
Operating income-$34.2M-8.8%
Net income-$33.2M-8.6%
EPS (diluted)-$0.21+12.5%

Balance sheet

See full
Cash & equivalents$108.9M+97.0%
Total debt$3.7M-32.2%
Total equity$246.1M+42.0%
Total assets$268.9M+28.1%

Cash flow

See full
Operating cash flow-$27.6M-63.4%
CapEx$1.0K-99.6%
Free cash flow-$27.6M-61.2%

Valuation

See full
Market cap$1.51B+268%
Enterprise value$1.41B+290%
P/S969.1×+870×

Profitability

See full
Operating margin-8,084.5%-17,708pp
Net margin-7,756.4%-17,069pp
FCF margin-6,981%-10,936pp

Returns & leverage

See full
Return on equity-57.7%+0.3pp
Debt / equity0.0×
Current ratio10.6×+6.2×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The source filing: Absci Corporation’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 4:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001672688-26-000136
(In thousands)For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization5,4246,072
Stock-based compensation9,6219,666
Accretion of discount on marketable securities(749)(1,368)
Other(487)(119)
Accounts receivable, net(700)
Prepaid expenses and other current assets(1,720)1,860
Operating lease right-of-use assets and liabilities(278)(268)

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Absci Corporation's accretion (amortization) of discounts and premiums, investments?
Absci Corporation (ABSI) reported accretion (amortization) of discounts and premiums, investments of $328K in Q2 2026.
How has Absci Corporation's accretion (amortization) of discounts and premiums, investments changed year-over-year?
Absci Corporation's accretion (amortization) of discounts and premiums, investments decreased by 51.0% year-over-year, from $669K to $328K.
What does accretion (amortization) of discounts and premiums, investments mean?
This represents the non-cash adjustment to reconcile net income for the amortization of premiums or the accretion of discounts on debt securities held as investments. It reflects the systematic recognition of interest income over the life of the investment to align the carrying value with the par value. This adjustment is essential for isolating the actual cash impact of investment activities from accounting-based interest income.

Ask your AI about Absci Corporation's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude